QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma 期刊论文 BLOOD ADVANCES, 2022, 卷号: 6 作者:  Yang, Haiyan;  Xiang, Bing;  Song, Yuqin;  Zhang, Huilai;  Zhao, Weili 收藏  |  浏览/下载：14/0  |  提交时间：2022/12/23 Bruton's tyrosine kinase inhibitors in primary central nervous system lymphoma-evaluation of anti-tumor efficacy and brain distribution 期刊论文 TRANSLATIONAL CANCER RESEARCH, 2021, 卷号: 10 作者:  Yu, Haifeng;  Kong, Haiying;  Li, Cong;  Dong, Xiaowu;  Wu, Yizhe 收藏  |  浏览/下载：21/0  |  提交时间：2021/08/31 Primary central nervous system lymphoma ( PCNSL)  Bruton's tyrosine kinase (BTK)  ibrutinib  zanubrutinib  tirabrutinib   Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial 期刊论文 BLOOD, 2018, 卷号: 132 作者:  Wang, Aihua;  Hilger, James;  Huang, Jane;  Novotny, William;  Osman, Muhtar 收藏  |  浏览/下载：24/0  |  提交时间：2019/12/05 Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial 会议论文 作者:  Song, Yuqin;  Zhou, Keshu;  Zou, Dehui;  Zhou, Jianfeng;  Hu, Jianda 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial 期刊论文 2018, 卷号: 132 作者:  Song, Yuqin;  Zhou, Keshu;  Zou, Dehui;  Zhou, Jianfeng;  Hu, Jianda 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03 Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial 会议论文 BLOOD, 2018-11-29 作者:  Song, Yuqin;  Zhou, Keshu;  Zou, Dehui;  Zhou, Jianfeng;  Hu, Jianda 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03